Safety and efficacy of MEDI0457 plus durvalumab in patients (pts) with human papillomavirus-associated recurrent/metastatic head and neck squamous cell carcinoma (HPV plus R/M HNSCC)

被引：16

作者：

Aggarwal, C. ^{[1
]}

Saba, N. F. ^{[2
]}

Algazi, A. P. ^{[3
]}

Sukari, A. ^{[4
]}

Seiwert, T. ^{[5
]}

Haigentz, M. ^{[6
]}

Porosnicu, M. ^{[7
]}

Bonomi, M. ^{[8
]}

Boyer, J. ^{[9
]}

Durham, N. ^{[10
]}

Kumar, R. ^{[11
]}

Laubscher, K. ^{[11
]}

Gong, M. ^{[12
]}

Ceaicovscaia, N. ^{[13
]}

Hernandez, A. Gasco ^{[13
]}

机构：

[1] Univ Penn, Abramson Canc Ctr, Raymond & Ruth Perelman Sch Med, Hematol Oncol, Philadelphia, PA 19104 USA

[2] Emory Univ, Hematol & Med Oncol, Atlanta, GA 30322 USA

[3] Univ Calif San Francisco, Hematol & Oncol, San Francisco, CA 94143 USA

[4] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

[5] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Head & Neck Canc Oncol Dis Grp, Baltimore, MD USA

[6] Morristown Med Ctr, Atlantic Hlth Syst, Morristown, NJ USA

[7] Wake Forest Sch Med, Dept Med, Sect Hematol Oncol, Winston Salem, NC 27101 USA

[8] Ohio State Univ, Med Oncol, Columbus, OH 43210 USA

[9] Inovio Pharmaceut, Analyt Sci, Philadelphia, PA USA

[10] AstraZeneca, Translat Med, Gaithersburg, MD USA

[11] AstraZeneca, Clin Operat, Gaithersburg, MD USA

[12] AstraZeneca, Biometr, Gaithersburg, MD USA

[13] AstraZeneca, Early Clin Dev, Gaithersburg, MD USA

来源：

关键词：

D O I：

10.1016/j.annonc.2020.08.1031

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

916MO

引用

页码：S661 / S662

页数：2